161 related articles for article (PubMed ID: 36759907)
1. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.
van Ginkel MS; Arends S; van der Vegt B; Nijland M; Spijkervet FKL; Vissink A; Kroese FGM; Glaudemans AWJM; Bootsma H
Rheumatology (Oxford); 2023 Oct; 62(10):3323-3331. PubMed ID: 36759907
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland 18F-FDG-PET/CT uptake patterns in Sjögren's syndrome and giant cell arteritis patients.
Grootelaar RGJ; van Ginkel MS; Nienhuis PH; Arends S; Pieterman RM; Brouwer E; Bootsma H; Glaudemans AWJM; Slart RHJA
Clin Exp Rheumatol; 2023 Dec; 41(12):2428-2436. PubMed ID: 38079331
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of
Keraen J; Blanc E; Besson FL; Leguern V; Meyer C; Henry J; Belkhir R; Nocturne G; Mariette X; Seror R
Arthritis Rheumatol; 2019 Jul; 71(7):1147-1157. PubMed ID: 30615273
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.
Cohen C; Mekinian A; Uzunhan Y; Fauchais AL; Dhote R; Pop G; Eder V; Nunes H; Brillet PY; Valeyre D; Fain O; Soussan M
Autoimmun Rev; 2013 Sep; 12(11):1109-14. PubMed ID: 23810977
[TBL] [Abstract][Full Text] [Related]
5. Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.
Jimenez-Royo P; Bombardieri M; Ciurtin C; Kostapanos M; Tappuni AR; Jordan N; Saleem A; Fuller T; Port K; Pontarini E; Lucchesi D; Janiczek R; Galette P; Searle G; Patel N; Kershaw L; Gray C; Ratia N; van Maurik A; de Groot M; Wisniacki N; Bergstrom M; Tarzi R
Rheumatology (Oxford); 2021 May; 60(5):2396-2408. PubMed ID: 33221921
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
7. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
8. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT in multisystem Sjögren syndrome.
Sharma P; Chatterjee P
Clin Nucl Med; 2015 May; 40(5):e293-4. PubMed ID: 25674865
[TBL] [Abstract][Full Text] [Related]
14. Correlation between
Zhao J; Wang H
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):188-194. PubMed ID: 33538120
[TBL] [Abstract][Full Text] [Related]
15. The role of
Wang W; Ni X; Tang T; Wang J; Li Y; Song X
Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
[TBL] [Abstract][Full Text] [Related]
16. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in splenic marginal zone lymphoma.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.
Shimizu M; Okamura K; Kise Y; Takeshita Y; Furuhashi H; Weerawanich W; Moriyama M; Ohyama Y; Furukawa S; Nakamura S; Yoshiura K
Arthritis Res Ther; 2015 Aug; 17(1):223. PubMed ID: 26298875
[TBL] [Abstract][Full Text] [Related]
20. The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function.
Li JF; Qin LP; Wu QY; Guo XH; Yang JZ; Wan QC; Cheng MH; Xie LJ
Clin Rheumatol; 2022 May; 41(5):1543-1550. PubMed ID: 35089469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
